|
1
|
Wee JT, Ha TC, Loong SL and Qian CN: Is
nasopharyngeal cancer really a ‘Cantonese cancer’? Chin J Cancer.
29:517–526. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Guo XC, Scott K, Liu Y, Dean M, David V,
Nelson GW, Johnson RC, Dilks HH, Lautenberger J, Kessing B, et al:
Genetic factors leading to chronic Epstein-Barr virus infection and
nasopharyngeal carcinoma in South East China: Study design, methods
and feasibility. Hum Genomics. 2:365–375. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Försti A, Jin Q, Altieri A, Johansson R,
Wagner K, Enquist K, Grzybowska E, Pamula J, Pekala W, Hallmans G,
et al: Polymorphisms in the KDR and POSTN genes: Association with
breast cancer susceptibility and prognosis. Breast Cancer Res
Treat. 101:83–93. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Folkman J: Tumor angiogenesis: Therapeutic
implications. N Engl J Med. 285:1182–1186. 1971. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Carmeliet P and Jain RK: Angiogenesis in
cancer and other diseases. Nature. 407:249–257. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Guo P, Xu L, Pan S, Brekken RA, Yang ST,
Whitaker GB, Nagane M, Thorpe PE, Rosenbaum JS, Huang Su HJ, et al:
Vascular endothelial growth factor isoforms display distinct
activities in promoting tumor angiogenesis at different anatomic
sites. Cancer Res. 61:8569–8577. 2001.PubMed/NCBI
|
|
7
|
Brenner RM, Nayak NR, Slayden OD,
Critchley HO and Kelly RW: Premenstrual and menstrual changes in
the macaque and human endometrium: Relevance to endometriosis. Ann
N Y Acad Sci. 955(60–74): 86–88, 396–406. 2002.
|
|
8
|
Qi L, Robinson WA, Brady BM and Glode LM:
Migration and invasion of human prostate cancer cells is related to
expression of VEGF and its receptors. Anticancer Res. 23:3917–3922.
2003.PubMed/NCBI
|
|
9
|
Waltenberger J, Claesson-Welsh L, Siegbahn
A, Shibuya M and Heldin CH: Different signal transduction
properties of KDR and Flt1, two receptors for vascular endothelial
growth factor. J Biol Chem. 269:26988–26995. 1994.PubMed/NCBI
|
|
10
|
Iughetti P, Suzuki O, Godoi PH, Alves VA,
Sertié AL, Zorick T, Soares F, Camargo A, Moreira ES, di Loreto C,
et al: A polymorphism in endostatin, an angiogenesis inhibitor,
predisposes for the development of prostatic adenocarcinoma. Cancer
Res. 61:7375–7378. 2001.PubMed/NCBI
|
|
11
|
Howell WM, Bateman AC, Turner SJ, Collins
A and Theaker JM: Influence of vascular endothelial growth factor
single nucleotide polymorphisms on tumour development in cutaneous
malignant melanoma. Genes Immun. 3:229–232. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Balasubramanian SP, Brown NJ and Reed MW:
Role of genetic polymorphisms in tumour angiogenesis. Br J Cancer.
87:1057–1065. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang Y, Zheng Y, Zhang W, Yu H, Lou K,
Zhang Y, Qin Q, Zhao B, Yang Y and Hui R: Polymorphisms of KDR Gene
are associated with coronary heart disease. J Am Coll Cardiol.
50:760–767. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Thompson L: World Health Organization
classification of tumours: Pathology and genetics of head and neck
tumours. Ear Nose Throat J. 85:742006.PubMed/NCBI
|
|
15
|
Sobin LH, Gospodarowicz MK and Wittekind
C: TNM Classification of Malignant Tumors. 7th edition.
Wiley-Blackwell; Oxford: 2009
|
|
16
|
Patterson C, Perrella MA, Hsieh CM,
Yoshizumi M, Lee ME and Haber E: Cloning and functional analysis of
the promoter for KDR/flk-1, a receptor for vascular endothelial
growth factor. J Biol Chem. 270:23111–23118. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
An SJ, Chen ZH, Lin QX, Su J, Chen HJ, Lin
JY and Wu YL: The −271G>A polymorphism of kinase insert
domain-containing receptor gene regulates its transcription level
in patients with non-small cell lung cancer. BMC Cancer. 9:1442009.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang W, Sun K, Zhen Y, Wang D, Wang Y,
Chen J, Xu J, Hu FB and Hui R: VEGF receptor-2 variants are
associated with susceptibility to stroke and recurrence. Stroke.
40:2720–2726. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kariyazono H, Ohno T, Khajoee V, Ihara K,
Kusuhara K, Kinukawa N, Mizuno Y and Hara T: Association of
vascular endothelial growth factor (VEGF) and VEGF receptor gene
polymorphisms with coronary artery lesions of Kawasaki Disease.
Pediatr Res. 56:953–959. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kariž S and Petrovič D: Minor association
of kinase insert domain-containing receptor gene polymorphism
(rs2071559) with myocardial infarction in Caucasians with type 2
diabetes mellitus: Case-control cross-sectional study. Clin
Biochem. 47:192–196. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Shalaby F, Rossant J, Yamaguchi TP,
Gertsenstein M, Wu XF, Breitman ML and Schuh AC: Failure of
blood-island formation and vasculogenesis in Flk-1 deficient mice.
Nature. 376:62–66. 1995. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Duff SE, Jeziorska M, Rosa DD, Kumar S,
Haboubi N, Sherlock D, O'Dwyer ST and Jayson GC: Vascular
endothelial growth factors and receptors in colorectal cancer:
Implications for anti-angiogenic therapy. Eur J Cancer. 42:112–117.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hirakawa S, Kodama S, Kunstfeld R, Kajiya
K, Brown LF and Detmar M: VEGF-A induces tumor and sentinel lymph
node lymphangiogenesis and promotes lymphatic metastasis. J Exp
Med. 201:1089–1099. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Nagy VM, Buiga R, Brie I, Todor N, Tudoran
O, Ordeanu C, Virág P, Tarta O, Rus M and Bălăcescu O: Expression
of VEGF, VEGFR, EGFR, COX-2 and MVD in cervical carcinoma, in
relation with the response to radio-chemotherapy. Rom J Morphol
Embryol. 52:53–59. 2011.PubMed/NCBI
|
|
25
|
Rydén L, Jirström K, Haglund M, Stål O and
Fernö M: Epidermal growth factor receptor and vascular endothelial
growth factor receptor 2 are specific biomarkers in triple-negative
breast cancer. Results from a controlled randomized trial with
long-term follow-up. Breast Cancer Res Treat. 120:491–498. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Mele T, Generali D, Fox S, Brizzi MP,
Bersiga A, Milani M, Allevi G, Bonardi S, Aguggini S, Volante M, et
al: Anti-angiogenic effect of tamoxifen combined with epirubicin in
breast cancer patients. Breast Cancer Res Treat. 123:795–804. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wilhelm SM, Carter C, Tang L, Wilkie D,
McNabola A, Rong H, Chen C, Zhang X, Vincent P, McHugh M, et al:
BAY 43–9006 exhibits broad spectrum oral antitumor activity and
targets the RAF/MEK/ERK pathway and receptor tyrosine kinases
involved in tumor progression and angiogenesis. Cancer Res.
64:7099–7109. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Escudier B, Rini BI, Motzer RJ, Tarazi J,
Kim S, Huang X, Rosbrook B, English PA, Loomis AK and Williams JA:
Genotype correlations with blood pressure and efficacy from a
randomized phase iii trial of second-line axitinib versus sorafenib
in metastatic renal cell carcinoma. Clin Genitourin Cancer.
13:328–337. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zheng YB, Zhan MX, Zhao W, Liu B, Huang
JW, He X, Fu SR, Zhao Y, Li Y, Hu BS and Lu LG: The relationship of
kinase insert domain receptor gene polymorphisms and clinical
outcome in advanced hepatocellular carcinoma patients treated with
sorafenib. Med Oncol. 31:2092014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Novitskiy SV, Csiki I, Huang Y, Johnson
DH, Harth EM, Carbone DP and Dikov MM: Anti-vascular endothelial
growth factor treatment in combination with chemotherapy delays
hematopoietic recovery due to decreased proliferation of bone
marrow hematopoietic progenitor cells. J Thorac Oncol. 5:1410–1415.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hlatky L, Hahnfeldt P and Folkman J:
Clinical application of antiangiogenic therapy: Microvessel
density, what it does and doesn't tell us. J Natl Cancer Inst.
94:883–893. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Vermeulen PB, Gasparini G, Fox SB,
Colpaert C, Marson LP, Gion M, Beliën JA, de Waal RM, Van Marck E,
Magnani E, et al: Second international consensus on the methodology
and criteria of evaluation of angiogenesis quantification in solid
human tumours. Eur J Cancer. 38:1564–1579. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Park HW, Shin ES, Lee JE, Kwon HS, Chun E,
Kim SS, Chang YS, Kim YK, Min KU, Kim YY and Cho SH: Multilocus
analysis of atopy in Korean children using
multifactor-dimensionality reduction. Thorax. 62:265–269. 2007.
View Article : Google Scholar : PubMed/NCBI
|
